Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q6NSJ0
UPID:
MYORG_HUMAN
Alternative names:
Uncharacterized family 31 glucosidase KIAA1161
Alternative UPACC:
Q6NSJ0; Q5T587; Q5T588; Q9ULQ9
Background:
The Myogenesis-regulating glycosidase, also known as Uncharacterized family 31 glucosidase KIAA1161, plays a pivotal role in muscle formation. It functions as a putative glycosidase and is instrumental in promoting myogenesis through the activation of AKT signaling, which is facilitated by the maturation and secretion of IGF2.
Therapeutic significance:
This protein is linked to Basal ganglia calcification, idiopathic, 7, autosomal recessive, a condition characterized by brain calcifications and a spectrum of neuropsychiatric symptoms. Understanding the role of Myogenesis-regulating glycosidase could open doors to potential therapeutic strategies for this and related disorders.